We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 123

Sanofi v. Hospira, merits of a 55.2 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court refused to grant an Order of Prohibition against Hospira regarding its docetaxel product

Lilly v Novopharm; motion to dismiss appeal for mootness; November 6, 2007 - olanzapine

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 16 2007

The Federal Court of Appeal heard the respondent generic company's motion to dismiss the appeal on the basis of mootness

Bayer Inc. v. Canada (Health), listing decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • December 3 2009

The Court dismissed a judicial review of the Minister’s decision refusing to list a formulation patent on the Patent Register

Sanofi v ratiopharm, PMNOC Regulations decision irbesartan, March 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Sanofi sought an order prohibiting the granting of a NOC to ratiopharm

Eli Lilly Canada Inc. v. Apotex; application to declare NOA null and void

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

Apotex sent a NOA regarding the validity of a patent list on the Patent Register for an orally disintegrating tablet form of a drug

Pfizer v Ranbaxy; 55.2 proceeding; October 5, 2007 - atorvastatin

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • October 25 2007

The trial judge granted prohibition in respect of one patent claiming a novel crystalline form of atorvastatin (the "crystalline form patent") and denied prohibition in respect of another patent claiming a novel process for making atorvastatin (the "process patent"

Recent cases

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • June 19 2008

The Court upheld the Minister's decision that the NOC approved use is different from the claimed use in the patent

Janssen-Ortho v. Apotex; motion for a stay; 2009 FCA 250; tramadol and acetaminophen; August 20, 2009

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • September 30 2009

In the Courts below, Apotex brought a motion to dismiss the application

Apotex v. Adir

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • July 27 2009

The Court of Appeal upheld the decision of the Trial Division finding that the patent was both valid and infringed

Eli Lilly and Company successful in patent infringement action against Apotex

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • November 2 2009

On October 1, 2009, Justice Gauthier of the Federal Court of Canada rendered a decision upholding the validity of eight process patents relating to intermediates used in the production of the antibiotic cefaclor